On October 8, SBP GROUP fell 3.08% in regular trading, reporting at HK$5.5, with turnover of HK$372 million.
Within the Pharmaceuticals sector where SBP GROUP belongs, the overall sector showed weakness. Among individual stocks, CF PHARMTECH fell 16.49%, CSPC PHARMA fell 5.15%, HANSOH PHARMA fell 4.30%, HUTCHMED fell 2.78%, and HENGRUI PHARMA fell 1.30%.
SBP GROUP is an investment holding company principally engaged in pharmaceutical business. The company operates through three segments: Modern Chinese Medicine Preparations and Western Medicine segment, which is engaged in the production, sales, and distribution of modern Chinese medicine preparations and Western medicine products; Investment segment, which is engaged in long-term investment business; and Other segment, which is engaged in related medical and hospital business.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)